Commonwealth Equity Services’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
BCIM
ERSOT
JSAM
TRCT
AT
Commonwealth Equity Services's PPH Position: Q1 2026 in Review
Commonwealth Equity Services increased its VanEck Pharmaceutical ETF (PPH) stake by 11% in Q1 2026, buying an estimated $122K and bringing the position to 11,842 shares worth $1.23M. The position accounts for ﹤0.01% of the portfolio, ranked #2426.
Commonwealth Equity Services first reported a position in PPH in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.93M in Q1 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.
- Commonwealth Equity Services held 11,842 shares of VanEck Pharmaceutical ETF worth $1.23M as of Q1 2026.
- Commonwealth Equity Services bought 1,143 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $122K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q1 2026, its #2426 holding.
- Commonwealth Equity Services first reported a position in VanEck Pharmaceutical ETF in Q2 2020 and has held it in 24 quarters since.
- Commonwealth Equity Services's VanEck Pharmaceutical ETF position peaked at $1.93M in Q1 2024.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.